相关实验视频
Updated: Jan 13, 2026

05:56
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
2.5K
救护车患者的炎症失衡与败血症和败血症休克有关
Kedeye Tuerxun1, Lisa Kurland2, Eva Särndahl1
1School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Inflammatory Response and Infection Susceptibility Centre, (iRiSC), Örebro University, Örebro, Sweden.
Cytokine
|January 11, 2026
概括
败血症患者表现出改变的单细胞免疫反应,其特征是较低的HLA-DRA和TNF/IL-10比率. 像HGF和HIF1A这样的特定标志物表明败血症休克的严重程度增加,这表明免疫抑制与败血症结局的联系.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 临床医学 临床医学
背景情况:
- 败血症涉及复杂的宿主免疫反应,单细胞起着关键作用.
- 之前的工作确定了特定的体外单细胞对内毒素 (LPS) 耐受性的反应概况.
- 在体内了解这些特征对于败血症诊断和预后至关重要.
研究的目的:
- 评估不同感染和败血症状态的患者中特定单细胞衍生的分子标记物的表达水平.
- 将这些标记物表达水平与诸如败血症休克和住院死亡率之类的临床结果联系起来.
- 调查单细胞响应概况与败血症严重程度之间的联系.
主要方法:
- 分析了809名救护车患者,根据感染和败血症状况分类.
- 在单细胞中测量了八种细胞因子/化学因子和五种转录因子的表达水平.
- 分子标记表达与临床结果的相关性,包括败血症休克和死亡率.
主要成果:
- 与非败血症患者相比,败血症患者的HLA-DRA表达和TNF/IL-10比率显著降低.
- 大多数其他研究的细胞因子/化学因子和基因表达在败血症患者中都升高.
- 感染性休克患者显示HGF,CCL8,CCL2,TNF,IL-10的水平较高,HIF1A和NFKBIA的升调.
结论:
- 与免疫抑制单细胞反应相关的特定免疫标记与败血症有关.
- 变化的单细胞表达特征,包括减少的HLA-DRA和TNF/IL-10比率,是败血症的特征.
- 像HGF,CCL8,CCL2,TNF,IL-10,HIF1A和NFKBIA这样的高标志物与败血症休克严重程度相关.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
1.5K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.5K
Inflammatory Response I: Vascular and Cellular
15.9K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
15.9K
Inflammation
61.5K
Overview
61.5K
Inflammatory Response
15.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
7.3K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.3K
Pulmonary Embolism I: Introduction
492
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
492

